James Fox, Director at Biota Pharmaceuticals, Inc. (BOTA), bought 70,000 shares at $1.99 ($139K) on 2015-06-09, disclosed to the SEC on 2015-06-11.
Open-market purchase of $139k BOTA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| BOTA | BUY | 2015-06-15 | $142K | — | Filing → |
| GNMK | BUY | 2012-06-28 | $100K | — | Filing → |